EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response

María Sánchez-Aguilar iD, Luz Ibarra-Lara iD, Agustina Cano-Martínez, Elizabeth Soria-Castro, Vicente Castrejón-Téllez, Natalia Pavón iD, Citlalli Osorio-Yáñez, Eulises Díaz-Díaz, María Esther Rubio-Ruíz iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von María Sánchez-Aguilar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico. Hauptthemen laut MEDLINE: Metabolic Syndrome, Reperfusion Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome (MetS) is a cluster of factors that increase the risk of developing diabetes, stroke, and heart failure. The pathophysiology of injury by ischemia/reperfusion (I/R) is highly complex and the inflammatory condition plays an important role by increasing matrix remodeling and cardiac apoptosis. Natriuretic peptides (NPs) are cardiac hormones with numerous beneficial effects mainly mediated by a cell surface receptor named atrial natriuretic peptide receptor (ANPr). Although NPs are powerful clinical markers of cardiac failure, their role in I/R is still controversial. Peroxisome proliferator-activated receptor α agonists exert cardiovascular therapeutic actions; however, their effect on the NPs’ signaling pathway has not been extensively studied. Our study provides important insight into the regulation of both ANP and ANPr in the hearts of MetS rats and their association with the inflammatory conditions caused by damage from I/R. Moreover, we show that pre-treatment with clofibrate was able to decrease the inflammatory response that, in turn, decreases myocardial fibrosis, the expression of metalloprotease 2 and apoptosis. Treatment with clofibrate is also associated with a decrease in ANP and ANPr expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeReperfusion InjuryRatsAnimalsAtrial Natriuretic FactorPPAR alphaClofibrateReceptors, Atrial Natriuretic FactorNatriuretic PeptidesIschemiaArrhythmias, CardiacInflammation

Stichwörter der Autor:innen

PPAR alpha agonistcardiac inflammationcardiac remodelingischemia/reperfusion injurymetabolic syndromenatriuretic peptides

Substanzen

Atrial Natriuretic FactorPPAR alphaClofibrateReceptors, Atrial Natriuretic FactorNatriuretic Peptides

Autor:innen und Institutionen

  • Department of Pharmacology, Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.
  • Department of Physiology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, Mexico.
  • Department of Cardiovascular Biomedicine, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, Mexico.
  • Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad Universitaria, Apartado Postal 70228, Ciudad de México 04510, Mexico.
  • Laboratorio de Fisiología Cardiovascular y Transplante Renal, Unidad de Investigación UNAM-INCICH, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, Mexico.
  • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y de la Nutrición "Salvador Zubirán", Vasco de Quiroga 15, Sección XVI, Tlalpan, México City 14000, Mexico.

ORCID-Profile: María Sánchez-Aguilar, Luz Ibarra-Lara, Natalia Pavón, María Esther Rubio-Ruíz

Förderung

  • Consejo Nacional de Ciencia y Tecnología

Zitieren

APA

Sánchez-Aguilar, M., Ibarra-Lara, L., Cano-Martínez, A., Soria-Castro, E., Castrejón-Téllez, V., Pavón, N., Osorio-Yáñez, C., Díaz-Díaz, E., & Rubio-Ruíz, M. E. (2023). PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065321

Vancouver

Sánchez-Aguilar M, Ibarra-Lara L, Cano-Martínez A, Soria-Castro E, Castrejón-Téllez V, Pavón N, et al. PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065321

BibTeX
@article{SnchezAguilar2023,
  author = {Sánchez-Aguilar, María and Ibarra-Lara, Luz and Cano-Martínez, Agustina and Soria-Castro, Elizabeth and Castrejón-Téllez, Vicente and Pavón, Natalia and Osorio-Yáñez, Citlalli and Díaz-Díaz, Eulises and Rubio-Ruíz, María Esther},
  title = {PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065321}
}
Kostenlos starten →